Search research articles
Contact Us
Filters
Showing results (841-850 of 978) with videos related to
Page
of 98
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study]
M Ikeda, T Taguchi, K Ota, et al.
The Journal of Biological Chemistry
|
March 25, 1994
Structural studies of a novel type of pentaantennary large glycan unit in the fertilization-associated carbohydrate-rich glycopeptide isolated from the fertilized eggs of Oryzias latipes
T Taguchi, A Seko, K Kitajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 1, 1993
[Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Cancer (third report): five-year results after surgery]
O Nishida, J Uchino, K Kikuchi, et al.
Biken Journal
|
March 1, 1982
Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence
K Ikuta, Y Nishi, Y Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1992
[Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs]
J Ota, T Taguchi, K Sakai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1992
[Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs]
N Nukariya, H Niitani, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1992
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs]
M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1995
[Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group]
K Sugano, K Ota, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1995
[Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C]
M Kurihara, G Kosaki, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 1, 1992
[A phase I study of DWA2114R]
Y Ariyoshi, A Wakui, K Hasegawa, et al.
Page
of 98
Search research articles
Search
Showing results (841-850 of 978) with videos related to
Sort By:
Page
of 98
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study]
M Ikeda, T Taguchi, K Ota, et al.
The Journal of Biological Chemistry
|
March 25, 1994
Structural studies of a novel type of pentaantennary large glycan unit in the fertilization-associated carbohydrate-rich glycopeptide isolated from the fertilized eggs of Oryzias latipes
T Taguchi, A Seko, K Kitajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 1, 1993
[Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Cancer (third report): five-year results after surgery]
O Nishida, J Uchino, K Kikuchi, et al.
Biken Journal
|
March 1, 1982
Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence
K Ikuta, Y Nishi, Y Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1992
[Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs]
J Ota, T Taguchi, K Sakai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1992
[Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs]
N Nukariya, H Niitani, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1992
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs]
M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1995
[Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group]
K Sugano, K Ota, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1995
[Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C]
M Kurihara, G Kosaki, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 1, 1992
[A phase I study of DWA2114R]
Y Ariyoshi, A Wakui, K Hasegawa, et al.
Page
of 98